Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03898388 · ClinicalTrials.gov registry record · NA
Correlating the OA Knee Microenvironment to Outcomes After Regenexx-SD Treatment: A Multi-Site Study
A NA study, sponsored by Regenexx.
- Terminated
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT03898388 is a NA study that was terminated before completion, run by Regenexx. The registered enrollment target is 47 participants.
The verdict
NCT03898388, a NA study, was terminated before completion, sponsored by Regenexx.
- TERMINATED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
Multi-center study to include up to 600 subjects with knee osteoarthritis in unilateral or bilateral knees treated with Regenexx® SD in the osteoarthritic knee/s. Synovial fluid drawn from patients' knee/s prior to receiving Regenexx-SD treatment will be correlated with their clinical outcomes after treatment.
Interventions
- PROCEDURE Bone Marrow Concentrate treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2019-03-21 |
| Est. Completion | 2022-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03898388
The ClinicalTrials.gov registry entry for NCT03898388 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Regenexx, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bone Marrow Concentrate treatment is the first listed.
NCT03898388 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03898388 about?
NCT03898388 is a clinical study titled "Correlating the OA Knee Microenvironment to Outcomes After Regenexx-SD Treatment: A Multi-Site Study". Multi-center study to include up to 600 subjects with knee osteoarthritis in unilateral or bilateral knees treated with Regenexx® SD in the osteoarthritic knee/s. Synovial fluid drawn from patients' knee/s prior to receiving Regenexx-SD treatment will be correlated with their clinical outcomes after...
What is the current status of trial NCT03898388?
This trial is currently terminated. It is a NA study. The enrollment target is 47 participants. The study started on 2019-03-21. Estimated completion is 2022-03-30.
What interventions are being tested in trial NCT03898388?
The interventions under investigation include: Bone Marrow Concentrate treatment (PROCEDURE).
Who is sponsoring clinical trial NCT03898388?
This trial is sponsored by Regenexx, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.